Plain-English translation of NCT06194591 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a medical device called Nephrospec that delivers low-intensity shock waves to your kidneys to help lower blood pressure. The shock waves are similar to technology used to break up kidney stones, but at much lower power. Early research suggests this treatment may reduce blood pressure and help protect kidney function in people with both high blood pressure and chronic kidney disease.
Many people with chronic kidney disease struggle to control their blood pressure even while taking medications. This trial is testing whether this new treatment could offer additional help by improving how blood flows through and oxygenates the kidneys, potentially leading to better blood pressure control and slowing kidney disease progression.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either active shock wave treatments or sham (fake) treatments to your kidneys over three weeks. If you receive the active treatment, you'll get 6 sessions during this time. You'll then be followed for 48 weeks with blood pressure checks and kidney function tests. If you're in the sham group and don't see improvement, you'll have the option to receive the active treatment in a follow-up phase.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
Switzerland